Effect of dihydroartemisinin on the expression of BCR/ABL fusion gene in leukemia K562 cells

Chinese Journal of Medical Genetics

Volumn 29, Issue 1, 2012, Pages 19-22

  Gao, Jia Liang ^a,b   Ding, Xian Ping ^a   Li, Qi Jie ^a   Xia, Zeng Liang ^a   Xia, Qing Jie ^a  

^a SICHUAN UNIVERSITY   (China)

^b Chengdu Blood Center   (China)

Author keywords

BCR ABL fusion gene; Dihydroartemisinin; K562 cells; Leukemia

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; DIHYDROARTEMISININ;

APOPTOSIS; ARTICLE; BCR ABL FUSION GENE; CANCER INHIBITION; CELL PROLIFERATION; CELL STRAIN K 562; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; FLOW CYTOMETRY; FUSION GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ARTEMISININS; FUSION PROTEINS, BCR-ABL; GENE EXPRESSION; GENES, ABL; HUMANS; K562 CELLS; LEUKEMIA; TUMOR CELLS, CULTURED;

EID: 84863262047     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1003-9406.2012.01.006     Document Type: Article

References (10)

1. Mu HJ, Xie P, Shen YF, et al. The expression of BCR/ABL fusion gene and FoxO3a transcription factor in the patients with primary or crisis blast chronic myeloid leukemia. Acta Univ Med Nanjing, 2008, 28: 190-193.
2. Wu GL, Zhu WB. The therapeutic progress of chronic myelogenous leukemia. Med Recapitulate, 2006, 11: 1329-1332.
3. Beekman AC, Wierenga PK, Woerdenbag HJ, et al. Artemisinin-derived sesquiterpene lactones as potential antitumour compounds: cytotoxic action against bone marrow and tumour cells. Planta Med, 1998, 64: 615-619. (Pubitemid 28481473)
4. Galal AM, Ross SA, Elsohly MA, et al. Deoxyartemisinin derivatives from photooxygenation of anhydrodeoxydihydro-artemisinin and their cytotoxic evaluation. J Nat Prod, 2002, 65: 184-188. (Pubitemid 34171179)
5. Green DR, Reed JC. Mitochondrion and apoptosis. Science, 1998, 281: 1309-1312.
6. Singh NP, Lai H. Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells. Life Sci, 2001, 70: 49-56. (Pubitemid 33130042)
7. Hou JM, Wang DS, Zhang RW, et al. Experimental therapy of hepatoma with artemisinin and its derivatives: in vitro and in vivo activity: chemosensitization and mechanisms of action. Clin Cancer Res, 2008, 14: 5519-5530.
8. Chen T, Li M, Zhang R, et al. Dihydroartemisinin induces apoptosis and sensitizes human ovarian cancer cells to carboplatin therapy. J Cell Mol Med, 2009, 13: 1358-1370.
9. Roninson IB. Tumor senescence as a determinant of drug response in vivo. Drug Resist Updat, 2002, 5: 204-208. (Pubitemid 35429450)
10. Zhou HJ, Wang Z, Li A. Dihydroartemisinin induces apoptosis in human leukemia cells HL60 via downregulation of transferring receptor expression. Anticancer Drugs, 2008, 19: 247-255.